-
1
-
-
20044373069
-
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension
-
Brunner H, Cockcroft JR, Deanfield J, et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23: 233-46.
-
(2005)
J Hypertens
, vol.23
, pp. 233-246
-
-
Brunner, H.1
Cockcroft, J.R.2
Deanfield, J.3
-
2
-
-
0030737530
-
The physiology and pathophysiology of the nitric oxide/superoxide system
-
Munzel T, Heitzer T, Harrison DG. The physiology and pathophysiology of the nitric oxide/superoxide system. Herz 1997; 22: 158-72.
-
(1997)
Herz
, vol.22
, pp. 158-172
-
-
Munzel, T.1
Heitzer, T.2
Harrison, D.G.3
-
3
-
-
0141615827
-
Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I
-
Creager MA, Luscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003; 108: 1527-32.
-
(2003)
Circulation
, vol.108
, pp. 1527-1532
-
-
Creager, M.A.1
Luscher, T.F.2
Cosentino, F.3
Beckman, J.A.4
-
4
-
-
84882336972
-
Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I
-
Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J 2013; 34: 2436-43.
-
(2013)
Eur Heart J
, vol.34
, pp. 2436-2443
-
-
Paneni, F.1
Beckman, J.A.2
Creager, M.A.3
Cosentino, F.4
-
5
-
-
33645780634
-
Endothelial nitric oxide synthase in vascular disease: From marvel to menace
-
Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006; 113: 1708-14.
-
(2006)
Circulation
, vol.113
, pp. 1708-1714
-
-
Forstermann, U.1
Munzel, T.2
-
6
-
-
84859487532
-
Nitric oxide synthases: Regulation and function
-
Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J 2012; 33: 829-37.
-
(2012)
Eur Heart J
, vol.33
, pp. 829-837
-
-
Forstermann, U.1
Sessa, W.C.2
-
7
-
-
78349297565
-
Oxidative stress and diabetic complications
-
Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010; 107: 1058-70.
-
(2010)
Circ Res
, vol.107
, pp. 1058-1070
-
-
Giacco, F.1
Brownlee, M.2
-
8
-
-
33746920337
-
Advanced glycation end products: Sparking the development of diabetic vascular injury
-
Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006; 114: 597-605.
-
(2006)
Circulation
, vol.114
, pp. 597-605
-
-
Goldin, A.1
Beckman, J.A.2
Schmidt, A.M.3
Creager, M.A.4
-
9
-
-
84903698784
-
Role of AGEs-RAGE system in cardiovascular disease
-
Fukami K, Yamagishi S, Okuda S. Role of AGEs-RAGE system in cardiovascular disease. Curr Pharm Des 2014; 20: 2395-402.
-
(2014)
Curr Pharm Des
, vol.20
, pp. 2395-2402
-
-
Fukami, K.1
Yamagishi, S.2
Okuda, S.3
-
10
-
-
34447528959
-
Arginase: A critical regulator of nitric oxide synthesis and vascular function
-
Durante W, Johnson FK, Johnson RA. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 2007; 34: 906-11.
-
(2007)
Clin Exp Pharmacol Physiol
, vol.34
, pp. 906-911
-
-
Durante, W.1
Johnson, F.K.2
Johnson, R.A.3
-
11
-
-
84883704050
-
The subcellular compartmentalization of arginine metabolizing enzymes and their role in endothelial dysfunction
-
Chen F, Lucas R, Fulton D. The subcellular compartmentalization of arginine metabolizing enzymes and their role in endothelial dysfunction. Front Immunol 2013; 4: 184.
-
(2013)
Front Immunol
, vol.4
, pp. 184
-
-
Chen, F.1
Lucas, R.2
Fulton, D.3
-
13
-
-
84883757525
-
Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity
-
Yang J, Gonon AT, Sjoquist PO, Lundberg JO, Pernow J. Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity. Proc Nat Acad Sci USA 2013; 110: 15049-54.
-
(2013)
Proc Nat Acad Sci USA
, vol.110
, pp. 15049-15054
-
-
Yang, J.1
Gonon, A.T.2
Sjoquist, P.O.3
Lundberg, J.O.4
Pernow, J.5
-
14
-
-
84877951082
-
Arginase as a potential target in the treatment of cardiovascular disease: Reversal of arginine steal?
-
Pernow J, Jung C. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc Res 2013; 98: 334-43.
-
(2013)
Cardiovasc Res
, vol.98
, pp. 334-343
-
-
Pernow, J.1
Jung, C.2
-
15
-
-
37849019273
-
Diabetes-induced coronary vascular dysfunction involves increased arginase activity
-
Romero MJ, Platt DH, Tawfik HE, et al. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res 2008; 102: 95-102.
-
(2008)
Circ Res
, vol.102
, pp. 95-102
-
-
Romero, M.J.1
Platt, D.H.2
Tawfik, H.E.3
-
16
-
-
35549002573
-
Possible involvement of enhanced arginase activity due to up-regulated arginases and decreased hydroxyarginine in accelerating intimal hyperplasia with hyperglycemia
-
Ishizaka M, Nagai A, Iwanaga M, Imamura M, Azuma H. Possible involvement of enhanced arginase activity due to up-regulated arginases and decreased hydroxyarginine in accelerating intimal hyperplasia with hyperglycemia. Vascul Pharmacol 2007; 47: 272-80.
-
(2007)
Vascul Pharmacol
, vol.47
, pp. 272-280
-
-
Ishizaka, M.1
Nagai, A.2
Iwanaga, M.3
Imamura, M.4
Azuma, H.5
-
17
-
-
79955150190
-
Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats
-
Grönros J, Jung C, Lundberg JO, Cerrato R, Ostenson CG, Pernow J. Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats. Am J Physiol 2011; 300: H1174-81.
-
(2011)
Am J Physiol
, vol.300
, pp. H1174-H1181
-
-
Grönros, J.1
Jung, C.2
Lundberg, J.O.3
Cerrato, R.4
Ostenson, C.G.5
Pernow, J.6
-
18
-
-
79955075627
-
Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes
-
Beleznai T, Feher A, Spielvogel D, Lansman SL, Bagi Z. Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes. Am J Physiol 2011; 300: H777-83.
-
(2011)
Am J Physiol
, vol.300
, pp. H777-H783
-
-
Beleznai, T.1
Feher, A.2
Spielvogel, D.3
Lansman, S.L.4
Bagi, Z.5
-
19
-
-
34547756859
-
MKP-1 switches arginine metabolism from nitric oxide synthase to arginase following endotoxin challenge
-
Nelin LD, Wang X, Zhao Q, et al. MKP-1 switches arginine metabolism from nitric oxide synthase to arginase following endotoxin challenge. Am J Physiol Cell Physiol 2007; 293: C632-C40.
-
(2007)
Am J Physiol Cell Physiol
, vol.293
, pp. C632-C640
-
-
Nelin, L.D.1
Wang, X.2
Zhao, Q.3
-
20
-
-
2942741190
-
Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells
-
Chicoine LG, Paffett ML, Young TL, Nelin LD. Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. Am J Physiol Lung Cell Mol Physiol 2004; 287: L60-88.
-
(2004)
Am J Physiol Lung Cell Mol Physiol
, vol.287
, pp. L60-L88
-
-
Chicoine, L.G.1
Paffett, M.L.2
Young, T.L.3
Nelin, L.D.4
-
21
-
-
34249319470
-
TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury
-
Gao X, Xu X, Belmadani S, et al. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 2007; 27: 1269-75.
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, pp. 1269-1275
-
-
Gao, X.1
Xu, X.2
Belmadani, S.3
-
22
-
-
84908660300
-
Increased arginase levels contribute to impaired perfusion after cardiopulmonary resuscitation
-
Jung C, Quitter F, Lichtenauer M, et al. Increased arginase levels contribute to impaired perfusion after cardiopulmonary resuscitation. Eur J Clin Invest 2014; 44: 965-71.
-
(2014)
Eur J Clin Invest
, vol.44
, pp. 965-971
-
-
Jung, C.1
Quitter, F.2
Lichtenauer, M.3
-
24
-
-
84926466287
-
Arginase induction and activation during ischemia and reperfusion and functional consequences for the heart
-
Schluter KD, Schulz R, Schreckenberg R. Arginase induction and activation during ischemia and reperfusion and functional consequences for the heart. Front Physiol 2015; 6: 65.
-
(2015)
Front Physiol
, vol.6
, pp. 65
-
-
Schluter, K.D.1
Schulz, R.2
Schreckenberg, R.3
-
25
-
-
33747429424
-
Upregulation of arginase by H2O2 impairs endothelium-dependent nitric oxide-mediated dilation of coronary arterioles
-
Thengchaisri N, Hein TW, Wang W, Xu X, Li Z, Fossum TW, Kuo L. Upregulation of arginase by H2O2 impairs endothelium-dependent nitric oxide-mediated dilation of coronary arterioles. Arterioscler Thromb Vasc Biol 2006; 26: 2035-42.
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 2035-2042
-
-
Thengchaisri, N.1
Hein, T.W.2
Wang, W.3
Xu, X.4
Li, Z.5
Fossum, T.W.6
Kuo, L.7
-
26
-
-
72049086478
-
Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia
-
Sankaralingam S, Xu H, Davidge ST. Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia. Cardiovasc Res 2010; 85: 194-203.
-
(2010)
Cardiovasc Res
, vol.85
, pp. 194-203
-
-
Sankaralingam, S.1
Xu, H.2
Davidge, S.T.3
-
27
-
-
83755224345
-
Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway
-
Chandra S, Romero M, Shatanawi A, Alkilany A, Caldwell R. Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway. Br J Pharmacol 2012; 165: 506-19.
-
(2012)
Br J Pharmacol
, vol.165
, pp. 506-519
-
-
Chandra, S.1
Romero, M.2
Shatanawi, A.3
Alkilany, A.4
Caldwell, R.5
-
28
-
-
84891781043
-
Endothelial dysfunction in diabetes: Pathogenesis, significance, and treatment
-
Hamilton SJ, Watts GF. Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment. Rev Diabet Stud 2013; 10: 133-56.
-
(2013)
Rev Diabet Stud
, vol.10
, pp. 133-156
-
-
Hamilton, S.J.1
Watts, G.F.2
-
29
-
-
84929055229
-
The role of arginase and rho kinase in cardioprotection from remote ischemic perconditioning in non-diabetic and diabetic rat in vivo
-
Kiss A, Tratsiakovich Y, Gonon AT, et al. The role of arginase and rho kinase in cardioprotection from remote ischemic perconditioning in non-diabetic and diabetic rat in vivo. PLoS One 2014; 9: e104731.
-
(2014)
Plos One
, vol.9
-
-
Kiss, A.1
Tratsiakovich, Y.2
Gonon, A.T.3
-
30
-
-
84874266181
-
Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout
-
Yao L, Chandra S, Toque HA, Bhatta A, Rojas M, Caldwell RB, Caldwell RW. Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout. Cardiovasc Res 2013; 97(3): 509-19.
-
(2013)
Cardiovasc Res
, vol.97
, Issue.3
, pp. 509-519
-
-
Yao, L.1
Chandra, S.2
Toque, H.A.3
Bhatta, A.4
Rojas, M.5
Caldwell, R.B.6
Caldwell, R.W.7
-
31
-
-
84905217813
-
OxLDL Triggers Retrograde Translocation of Arginase2 in Aortic Endothelial Cells via ROCK and Mitochondrial Processing Peptidase
-
Pandey D, Bhunia A, Oh YJ, et al. OxLDL Triggers Retrograde Translocation of Arginase2 in Aortic Endothelial Cells via ROCK and Mitochondrial Processing Peptidase. Circ Res 2014; 115: 450-9.
-
(2014)
Circ Res
, vol.115
, pp. 450-459
-
-
Pandey, D.1
Bhunia, A.2
Oh, Y.J.3
-
32
-
-
84900540044
-
Role for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesis
-
Aguilar H, Fricovsky E, Ihm S, et al. Role for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesis. Am J Physiol Cell Physiol 2014; 306: C794-804.
-
(2014)
Am J Physiol Cell Physiol
, vol.306
, pp. C794-C804
-
-
Aguilar, H.1
Fricovsky, E.2
Ihm, S.3
-
33
-
-
34848861137
-
Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction
-
Santhanam L, Lim HK, Miriel V, et al. Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ Res 2007; 101: 692-702.
-
(2007)
Circ Res
, vol.101
, pp. 692-702
-
-
Santhanam, L.1
Lim, H.K.2
Miriel, V.3
-
34
-
-
84864280255
-
Protein tyrosine phosphatase SHP2 mediates chronic insulin-induced endothelial inflammation
-
Giri H, Muthuramu I, Dhar M, Rathnakumar K, Ram U, Dixit M. Protein tyrosine phosphatase SHP2 mediates chronic insulin-induced endothelial inflammation. Arterioscler Thromb Vasc Biol 2012; 32: 1943-50.
-
(2012)
Arterioscler Thromb Vasc Biol
, vol.32
, pp. 1943-1950
-
-
Giri, H.1
Muthuramu, I.2
Dhar, M.3
Rathnakumar, K.4
Ram, U.5
Dixit, M.6
-
35
-
-
84883607506
-
Arginase: The emerging therapeutic target for vascular oxidative stress and inflammation
-
Yang Z, Ming XF. Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation. Front Immunol 2013; 4: 149.
-
(2013)
Front Immunol
, vol.4
, pp. 149
-
-
Yang, Z.1
Ming, X.F.2
-
36
-
-
0025862132
-
Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (Non-insulin-dependent) diabetic patients
-
Gall MA, Rossing P, Skott P, et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655-61.
-
(1991)
Diabetologia
, vol.34
, pp. 655-661
-
-
Gall, M.A.1
Rossing, P.2
Skott, P.3
-
37
-
-
79951976114
-
Arginase II Deletion Increases Corpora Cavernosa Relaxation in Diabetic Mice
-
Toque HA, Tostes RC, Yao L, Xu Z, Webb RC, Caldwell RB, Caldwell RW. Arginase II Deletion Increases Corpora Cavernosa Relaxation in Diabetic Mice. J Sex Med 2011; 8: 722-33.
-
(2011)
J Sex Med
, vol.8
, pp. 722-733
-
-
Toque, H.A.1
Tostes, R.C.2
Yao, L.3
Xu, Z.4
Webb, R.C.5
Caldwell, R.B.6
Caldwell, R.W.7
-
38
-
-
84862917687
-
The phenotype and functional alterations of macrophages in mice with hyperglycemia for long term
-
Sun C, Sun L, Ma H, et al. The phenotype and functional alterations of macrophages in mice with hyperglycemia for long term. J Cell Physiol 2011.
-
(2011)
J Cell Physiol
-
-
Sun, C.1
Sun, L.2
Ma, H.3
-
39
-
-
70350117109
-
Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats
-
Kim JH, Bugaj LJ, Oh YJ, et al. Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J Appl Physiol 2009; 107: 1249-57.
-
(2009)
J Appl Physiol
, vol.107
, pp. 1249-1257
-
-
Kim, J.H.1
Bugaj, L.J.2
Oh, Y.J.3
-
41
-
-
85047540084
-
The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes
-
Elms SC, Toque HA, Rojas M, Xu Z, Caldwell RW, Caldwell RB. The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes. Diabetologia 2012.
-
(2012)
Diabetologia
-
-
Elms, S.C.1
Toque, H.A.2
Rojas, M.3
Xu, Z.4
Caldwell, R.W.5
Caldwell, R.B.6
-
42
-
-
84883781263
-
Arginase promotes skeletal muscle arteriolar endothelial dysfunction in diabetic rats
-
Johnson FK, Johnson RA, Peyton KJ, Shebib AR, Durante W. Arginase promotes skeletal muscle arteriolar endothelial dysfunction in diabetic rats. Front Immunol 2013; 4: 119.
-
(2013)
Front Immunol
, vol.4
, pp. 119
-
-
Johnson, F.K.1
Johnson, R.A.2
Peyton, K.J.3
Shebib, A.R.4
Durante, W.5
-
43
-
-
72049107764
-
Arginase inhibition mediates cardioprotection during ischaemia-reperfusion
-
Jung C, Gonon AT, Sjoquist PO, Lundberg JO, Pernow J. Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. Cardiovasc Res 2010; 85: 147-54.
-
(2010)
Cardiovasc Res
, vol.85
, pp. 147-154
-
-
Jung, C.1
Gonon, A.T.2
Sjoquist, P.O.3
Lundberg, J.O.4
Pernow, J.5
-
44
-
-
84864490199
-
Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production
-
Gonon AT, Jung C, Katz A, et al. Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production. PLoS One 2012; 7: e42038.
-
(2012)
Plos One
, vol.7
-
-
Gonon, A.T.1
Jung, C.2
Katz, A.3
-
45
-
-
84882354610
-
Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part II
-
Beckman JA, Paneni F, Cosentino F, Creager MA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J 2013; 34: 2444-52.
-
(2013)
Eur Heart J
, vol.34
, pp. 2444-2452
-
-
Beckman, J.A.1
Paneni, F.2
Cosentino, F.3
Creager, M.A.4
-
46
-
-
84874266181
-
Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout
-
Yao L, Chandra S, Toque HA, Bhatta A, Rojas M, Caldwell RB, Caldwell RW. Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout. Cardiovasc Res 2013; 97: 509-19.
-
(2013)
Cardiovasc Res
, vol.97
, pp. 509-519
-
-
Yao, L.1
Chandra, S.2
Toque, H.A.3
Bhatta, A.4
Rojas, M.5
Caldwell, R.B.6
Caldwell, R.W.7
-
47
-
-
84871299118
-
Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus
-
Shemyakin A, Kovamees O, Rafnsson A, et al. Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus. Circulation 2012; 126: 2943-50.
-
(2012)
Circulation
, vol.126
, pp. 2943-2950
-
-
Shemyakin, A.1
Kovamees, O.2
Rafnsson, A.3
-
48
-
-
38149109904
-
Insulin reduces plasma arginase activity in type 2 diabetic patients
-
Kashyap SR, Lara A, Zhang R, Park YM, DeFronzo RA. Insulin reduces plasma arginase activity in type 2 diabetic patients. Diabetes Care 2008; 31: 134-9.
-
(2008)
Diabetes Care
, vol.31
, pp. 134-139
-
-
Kashyap, S.R.1
Lara, A.2
Zhang, R.3
Park, Y.M.4
Defronzo, R.A.5
-
49
-
-
84885997413
-
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
-
Ryden L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, prediabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Europ Heart J 2013; 34: 3035-87.
-
(2013)
The Task Force on Diabetes, Prediabetes, and Cardiovascular Diseases of the European Society of Cardiology (ESC) and Developed in Collaboration with the European Association for the Study of Diabetes (EASD). Europ Heart J
, vol.34
, pp. 3035-3087
-
-
Ryden, L.1
Grant, P.J.2
Anker, S.D.3
-
50
-
-
84904980514
-
Effect of Arginase Inhibition on Ischemia-Reperfusion Injury in Patients with Coronary Artery Disease with and without Diabetes Mellitus
-
Kovamees O, Shemyakin A, Pernow J. Effect of Arginase Inhibition on Ischemia-Reperfusion Injury in Patients with Coronary Artery Disease with and without Diabetes Mellitus. PLoS One 2014; 9: e103260.
-
(2014)
Plos One
, vol.9
-
-
Kovamees, O.1
Shemyakin, A.2
Pernow, J.3
-
51
-
-
84903397422
-
Endothelial dysfunction in chronic inflammatory diseases
-
Steyers CM, 3rd, Miller FJ, Jr. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci 2014; 15: 11324-49.
-
(2014)
Int J Mol Sci
, vol.15
, pp. 11324-11349
-
-
Steyers, C.M.1
Miller, F.J.2
-
52
-
-
33645399764
-
Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats
-
Johnson FK, Johnson RA, Durante W, Jackson KE, Stevenson BK, Peyton KJ. Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 2006; 290: R601-8.
-
(2006)
Am J Physiol Regul Integr Comp Physiol
, vol.290
, pp. R601-R608
-
-
Johnson, F.K.1
Johnson, R.A.2
Durante, W.3
Jackson, K.E.4
Stevenson, B.K.5
Peyton, K.J.6
-
53
-
-
84906934587
-
Arginase inhibition restores endothelial function in diet-induced obesity
-
Chung JH, Moon J, Lee YS, Chung HK, Lee SM, Shin MJ. Arginase inhibition restores endothelial function in diet-induced obesity. Biochem Biophys Res Commun 2014; 451: 179-83.
-
(2014)
Biochem Biophys Res Commun
, vol.451
, pp. 179-183
-
-
Chung, J.H.1
Moon, J.2
Lee, Y.S.3
Chung, H.K.4
Lee, S.M.5
Shin, M.J.6
-
54
-
-
84893638504
-
Increased levels of circulating arginase I in overweight compared to normal weight adolescents
-
Jung C, Figulla HR, Lichtenauer M, Franz M, Pernow J. Increased levels of circulating arginase I in overweight compared to normal weight adolescents. Pediatr Diabetes 2014; 15: 51-6.
-
(2014)
Pediatr Diabetes
, vol.15
, pp. 51-56
-
-
Jung, C.1
Figulla, H.R.2
Lichtenauer, M.3
Franz, M.4
Pernow, J.5
-
55
-
-
84860646985
-
Arginase I and the very low-density lipoprotein receptor are associated with phenotypic biomarkers for obesity
-
Kim OY, Lee SM, Chung JH, Do HJ, Moon J, Shin MJ. Arginase I and the very low-density lipoprotein receptor are associated with phenotypic biomarkers for obesity. Nutrition 2012; 28: 635-9.
-
(2012)
Nutrition
, vol.28
, pp. 635-639
-
-
Kim, O.Y.1
Lee, S.M.2
Chung, J.H.3
Do, H.J.4
Moon, J.5
Shin, M.J.6
-
56
-
-
84919418471
-
Functions of arginase isoforms in macrophage inflammatory responses: Impact on cardiovascular diseases and metabolic disorders
-
Yang Z, Ming XF. Functions of arginase isoforms in macrophage inflammatory responses: impact on cardiovascular diseases and metabolic disorders. Front Immunol 2014; 5: 533.
-
(2014)
Front Immunol
, vol.5
, pp. 533
-
-
Yang, Z.1
Ming, X.F.2
-
57
-
-
84880934027
-
Arginase II Promotes Macrophage Inflammatory Responses Through Mitochondrial Reactive Oxygen Species, Contributing to Insulin Resistance and Atherogenesis
-
Ming XF, Rajapakse AG, Yepuri G, et al. Arginase II Promotes Macrophage Inflammatory Responses Through Mitochondrial Reactive Oxygen Species, Contributing to Insulin Resistance and Atherogenesis. J Am Heart Assoc 2012; 1: e000992.
-
(2012)
J am Heart Assoc
, vol.1
-
-
Ming, X.F.1
Rajapakse, A.G.2
Yepuri, G.3
-
58
-
-
84897502656
-
Human adipose tissue macrophages are enhanced but changed to an anti-inflammatory profile in obesity
-
Fjeldborg K, Pedersen SB, Moller HJ, Christiansen T, Bennetzen M, Richelsen B. Human adipose tissue macrophages are enhanced but changed to an anti-inflammatory profile in obesity. J Immunol Res 2014; 2014: 309548.
-
(2014)
J Immunol Res
, vol.2014
-
-
Fjeldborg, K.1
Pedersen, S.B.2
Moller, H.J.3
Christiansen, T.4
Bennetzen, M.5
Richelsen, B.6
-
59
-
-
84906939601
-
Reciprocal effects of systemic inflammation and brain natriuretic peptide on adiponectin biosynthesis in adipose tissue of patients with ischemic heart disease
-
Antonopoulos AS, Margaritis M, Coutinho P, et al. Reciprocal effects of systemic inflammation and brain natriuretic peptide on adiponectin biosynthesis in adipose tissue of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol 2014; 34: 2151-9.
-
(2014)
Arterioscler Thromb Vasc Biol
, vol.34
, pp. 2151-2159
-
-
Antonopoulos, A.S.1
Margaritis, M.2
Coutinho, P.3
-
60
-
-
84877944898
-
The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes
-
Elms SC, Toque HA, Rojas M, Xu Z, Caldwell RW, Caldwell RB. The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes. Diabetologia 2013; 56: 654-62.
-
(2013)
Diabetologia
, vol.56
, pp. 654-662
-
-
Elms, S.C.1
Toque, H.A.2
Rojas, M.3
Xu, Z.4
Caldwell, R.W.5
Caldwell, R.B.6
-
61
-
-
84883240293
-
Arginase as a mediator of diabetic retinopathy
-
Patel C, Rojas M, Narayanan SP, et al. Arginase as a mediator of diabetic retinopathy. Front Immunol 2013; 4: 173.
-
(2013)
Front Immunol
, vol.4
, pp. 173
-
-
Patel, C.1
Rojas, M.2
Narayanan, S.P.3
-
62
-
-
80755152815
-
Arginase-2 mediates diabetic renal injury
-
Morris SM, Jr., Gao T, Cooper TK, Kepka-Lenhart D, Awad AS. Arginase-2 mediates diabetic renal injury. Diabetes 2011; 60: 3015-22.
-
(2011)
Diabetes
, vol.60
, pp. 3015-3022
-
-
Morris, S.M.1
Gao, T.2
Cooper, T.K.3
Kepka-Lenhart, D.4
Awad, A.S.5
-
63
-
-
84888646474
-
Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism
-
You H, Gao T, Cooper TK, Morris SM, Jr., Awad AS. Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism. Kidney Int 2013; 84: 1189-97.
-
(2013)
Kidney Int
, vol.84
, pp. 1189-1197
-
-
You, H.1
Gao, T.2
Cooper, T.K.3
Morris, S.M.4
Awad, A.S.5
-
64
-
-
84865641748
-
Arginase inhibition alleviates hypertension associated with diabetes: Effect on endothelial dependent relaxation and NO production
-
El-Bassossy HM, El-Fawal R, Fahmy A. Arginase inhibition alleviates hypertension associated with diabetes: effect on endothelial dependent relaxation and NO production. Vascul Pharmacol 2012; 57: 194-200.
-
(2012)
Vascul Pharmacol
, vol.57
, pp. 194-200
-
-
El-Bassossy, H.M.1
El-Fawal, R.2
Fahmy, A.3
-
65
-
-
0033040323
-
The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: Possible modulatory effects by transforming growth factor beta 1
-
Jude EB, Boulton AJ, Ferguson MW, Appleton I. The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1. Diabetologia 1999; 42: 748-57.
-
(1999)
Diabetologia
, vol.42
, pp. 748-757
-
-
Jude, E.B.1
Boulton, A.J.2
Ferguson, M.W.3
Appleton, I.4
-
66
-
-
84878736457
-
Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: Possible involvement of p38 MAPK activation
-
Toque HA, Nunes KP, Yao L, Liao JK, Webb RC, Caldwell RB, Caldwell RW. Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation. J Sex Med 2013; 10: 1502-15.
-
(2013)
J Sex Med
, vol.10
, pp. 1502-1515
-
-
Toque, H.A.1
Nunes, K.P.2
Yao, L.3
Liao, J.K.4
Webb, R.C.5
Caldwell, R.B.6
Caldwell, R.W.7
-
67
-
-
78649844792
-
P38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice
-
Toque HA, Romero MJ, Tostes RC, et al. p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice. J Sex Med 2010; 7: 3857-67.
-
(2010)
J Sex Med
, vol.7
, pp. 3857-3867
-
-
Toque, H.A.1
Romero, M.J.2
Tostes, R.C.3
-
68
-
-
0034816774
-
Increased expression of arginase II in human diabetic corpus cavernosum: In diabetic-associated erectile dysfunction
-
Bivalacqua TJ, Hellstrom WJ, Kadowitz PJ, Champion HC. Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun 2001; 283: 923-7.
-
(2001)
Biochem Biophys Res Commun
, vol.283
, pp. 923-927
-
-
Bivalacqua, T.J.1
Hellstrom, W.J.2
Kadowitz, P.J.3
Champion, H.C.4
-
69
-
-
84883773473
-
Role of arginase in vessel wall remodeling
-
Durante W. Role of arginase in vessel wall remodeling. Front Immunol 2013; 4: 111.
-
(2013)
Front Immunol
, vol.4
, pp. 111
-
-
Durante, W.1
-
70
-
-
84957415695
-
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
-
Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal TP, Hemmingsen C, Wetterslev J. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev 2013; 11: CD008143.
-
(2013)
Cochrane Database Syst Rev
, vol.11
-
-
Hemmingsen, B.1
Lund, S.S.2
Gluud, C.3
Vaag, A.4
Almdal, T.P.5
Hemmingsen, C.6
Wetterslev, J.7
-
71
-
-
80051547684
-
Arginase I attenuates inflammatory cytokine secretion induced by lipopolysaccharide in vascular smooth muscle cells
-
Wang XP, Chen YG, Qin WD, et al. Arginase I attenuates inflammatory cytokine secretion induced by lipopolysaccharide in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2011; 31: 1853-60.
-
(2011)
Arterioscler Thromb Vasc Biol
, vol.31
, pp. 1853-1860
-
-
Wang, X.P.1
Chen, Y.G.2
Qin, W.D.3
-
72
-
-
77954812507
-
Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension
-
Bagnost T, Ma L, da Silva RF, et al. Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension. Cardiovasc Res 2010; 87: 569-77.
-
(2010)
Cardiovasc Res
, vol.87
, pp. 569-577
-
-
Bagnost, T.1
Ma, L.2
da Silva, R.F.3
-
73
-
-
42549088600
-
Endothelial arginase II: A novel target for the treatment of atherosclerosis
-
Ryoo S, Gupta G, Benjo A, et al. Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res 2008; 102: 923-32.
-
(2008)
Circ Res
, vol.102
, pp. 923-932
-
-
Ryoo, S.1
Gupta, G.2
Benjo, A.3
-
74
-
-
77952958789
-
Modulating the NO generating system from a medicinal chemistry perspective: Current trends and therapeutic options in cardiovascular disease
-
Schade D, Kotthaus J, Clement B. Modulating the NO generating system from a medicinal chemistry perspective: current trends and therapeutic options in cardiovascular disease. Pharmacol Therap 2010; 126: 279-300.
-
(2010)
Pharmacol Therap
, vol.126
, pp. 279-300
-
-
Schade, D.1
Kotthaus, J.2
Clement, B.3
|